Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Upadacitinib on PharmaCompass.com

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11198697

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11773105

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3341

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11512092

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3487

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10597400

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3255

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9951080

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11186584

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10730883

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11773106

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3487

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

RE47221

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2030-12-01

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

RE47221

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2030-12-01

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11198697

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10550126

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3298

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11535624

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3255

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

RE47221

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2030-12-01

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10519164

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11767326

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3298

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11198697

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3624

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3255

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9963459

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10202393

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11795175

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3255

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11186584

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11512092

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3275

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11186584

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10981923

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10981924

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3341

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3624

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11780847

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3371

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11661425

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11767326

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3298

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10344036

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11564922

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2038-03-09

Patent Use Code

U-3624

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9951080

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3341

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11773105

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11773106

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3371

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10995095

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3298

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11680069

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10981923

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11512092

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-10-17

Patent Use Code

U-3371

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11607411

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2038-03-09

Patent Use Code

U-3341

Delist Requested

Application Number

211675

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11680069

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11661425

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8962629

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2031-01-15

Patent Use Code

U-3624

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11787815

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2036-10-17

Patent Use Code

Delist Requested

Application Number

211675

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

UPADACITINIB